Truvian added scientific advisors early on and provided potential investors an abundance of data.
Truvian’s big picture goal for this technology is for it to decentralize healthcare by bringing point-of-care (POC) diagnostic testing to a highly complex, distributed market.
“This is really about disrupting the way that industry is structured today,” CEO Jeff Hawkins said. “One of the core tenets to the approach we took to even developing this technology was [that] we wanted the point-of-care test to have similar dynamic ranges and similar precision and accuracy to the larger device.”
Compact and fully automated point-of-care blood testing solutions will certainly have a more prominent role as consumers demand the convenience of accessing test results at a local pharmacy, an on-site clinic, at work, or at a physician’s office.